J Korean Med Assoc Search


J Korean Med Assoc > Volume 46(9); 2003 > Article
Journal of the Korean Medical Association 2003;46(9):800-807.
DOI: https://doi.org/10.5124/jkma.2003.46.9.800   
Pharmacotherapy in the Treatment of Depression
In Ho Paik, Chi Un Pae
DDepartment of Psychiatry, The Catholic University of Korea, College of Medicine, Kangnam St. Mary's Hospital, Korea. nppih@chtholic.ac.kr, pae@chtholic.ac.kr
Some new antidepressants including mirtazapine and citalopram appear to have promising efficacy and tolerability in the treatment of depression. For most major depression, all antidepressant drugs have equal efficacy. The choice of antidepressant drug needs to be tailored to a particular patient's medical condition and personal preferences. It is likely that adverse effects are the major determinant in the choice of antidepressant for a particular patient. However, in treating conditions other than depression, the efficacy of the ntidepressant drug can be the primary issue of drug choice. In conclusion, we would like discuss the current status and future direction in the treatment of depression.
Key Words: Pharmacotherapy, Depression


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next